SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-22-019520
Filing Date
2022-04-13
Accepted
2022-04-13 08:17:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea158373-424b3_nlspharma.htm 424B3 7769
2 GRAPHIC image_001.jpg GRAPHIC 14050
3 GRAPHIC image_002.jpg GRAPHIC 6622
  Complete submission text file 0001213900-22-019520.txt   37486
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262489 | Film No.: 22823698
SIC: 2834 Pharmaceutical Preparations